Involvement of Endogenous Enkephalins and β-Endorphin in Feeding and Diet-Induced Obesity

Neuropsychopharmacology

Volumn 40, Issue 9, 2015, Pages 2103-2112

  Mendez, Ian A ^a   Ostlund, Sean B ^a,b   Maidment, Nigel T ^a   Murphy, Niall P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; DELTA OPIATE RECEPTOR; ENKEPHALIN; MU OPIATE RECEPTOR; PROENKEPHALIN; SUCROSE; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET INDUCED OBESITY; FEEDING BEHAVIOR; FEMALE; GENE INACTIVATION; LICKING; MALE; METABOLIC REGULATION; MOUSE; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; REWARD; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; APPETITE; CASE CONTROL STUDY; DIET; DISEASE MODEL; DOSE RESPONSE; DRINKING BEHAVIOR; FOOD DEPRIVATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; OBESITY; PHYSIOLOGY;

ANIMALS; APPETITE; BETA-ENDORPHIN; BODY WEIGHT; CASE-CONTROL STUDIES; DIET; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; ENKEPHALINS; FEEDING BEHAVIOR; FEMALE; FOOD DEPRIVATION; MALE; MICE; MICE, KNOCKOUT; OBESITY; PROTEIN PRECURSORS; SUCROSE;

EID: 84937162270     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.67     Document Type: Article

References (64)

1. Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM (1984). Endogenous opioids: biology and function. Annu Rev Neurosci 7: 223-255.
2. Appleyard SM, Hayward M, Young JI, Butler AA, Cone RD, Rubinstein M et al (2003). A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology 144: 1753-1760.
3. Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL (1985). Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther 38: 419-422.
4. Bachmanov AA, Tordoff MG, Beauchamp GK (2001). Sweetener preference of C57BL/6ByJ and 129P3/J mice. Chem Senses 26: 905-913.
5. Bakshi VP, Kelley AE (1993). Striatal regulation of morphine-induced hyperphagia: an anatomical mapping study. Psychophar-macology 111: 207-214.
6. Berridge KC (2009). 'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders. Physiol Behav 97: 537-550.
7. Berridge KC, Ho CY, Richard JM, DiFeliceantonio AG (2010). The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res 1350: 43-64.
8. Berridge KC, Robinson The (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309-369.
9. Berridge KC, Robinson TE, Aldridge JW (2009). Dissecting components of reward: 'liking', 'wanting', and learning. Curr Opin Pharmacol 9: 65-73.
10. Bodnar RJ, Glass MJ, Ragnauth A, Cooper ML (1995). General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res 700: 205-212.
11. Cambridge VC, Ziauddeen H, Nathan PJ, Subramaniam N, Dodds C, Chamberlain SR et al (2013). Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people. Biol Psychiatry 73: 887-894.
12. Czyzyk TA, Pico AR, Pintar J, McKinzie JH, Tschop MH, Statnick MA et al (2012). Mice lacking δ-opioid receptors resist the development of diet-induced obesity. FASEB J 26: 3483-3492.
13. D'Aquila PS (2010). Dopamine on D2-like receptors "reboosts" dopamine D1-like receptor-mediated behavioural activation in rats licking for sucrose. Neuropharmacology 58: 1085-1096.
14. Davis JD, Smith GP (1988). Analysis of lick rate measures the positive and negative feedback effects of carbohydrates on eating. Appetite 11: 229-238.
15. DiFeliceantonio AG, Mabrouk OS, Kennedy RT, Berridge KC (2012). Enkephalin surges in dorsal neostriatum as a signal to eat. Curr Biol 22: 1918-1924.
16. Doyle TG, Berridge KC, Gosnell BA (1993). Morphine enhances hedonic taste palatability in rats. Pharmacol Biochem Behav 46: 745-749.
17. Dwyer DM (2012). Licking and liking: the assessment of hedonic responses in rodents. Q J Exp Psychol 65: 371-394.
18. Farhang B, Pietruszewski L, Lutfy K, Wagner EJ (2010). The role of the NOP receptor in regulating food intake, meal pattern, and the excitability of proopiomelanocortin neurons. Neuropharmacology 59: 190-200.
19. Frank GK, Oberndorfer TA, Simmons AN, Paulus MP, Fudge JL, Yang TT et al (2008). Sucrose activates human taste pathways differently from artificial sweetener. Neuroimage 39: 1559-1569.
20. Frisina PG, Sclafani A (2002). Naltrexone suppresses the late but not early licking response to a palatable sweet solution: opioid hedonic hypothesis reconsidered. Pharmacol Biochem Behav 74: 163-172.
21. Fujiyama F, Sohn J, Nakano T, Furuta T, Nakamura KC, Matsuda W et al (2011). Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur J Neurosci 33: 668-677.
22. Galistu A, Modde C, Pireddu MC, Franconi F, Serra G, D'Aquila PS (2011). Clozapine increases reward evaluation but not overall ingestive behaviour in rats lickingfor sucrose. Psychopharmacol-ogy 216: 411-420.
23. Genn RF, Higgs S, Cooper SJ (2003). The effects of 7-OH-DPAT, quinpirole and raclopride on licking for sucrose solution in the non-deprived rat. Behav Pharmacol 14: 609-617.
24. Giraudo SQ, Grace MK, Billington CJ, Levine AS (1999). Differential effects of neuropeptide Y and the mu-agonist DAMGO on 'palatability' vs. 'energy'. Brain Res 834: 160-163.
25. Giuliano C, Robbins TW, Nathan PJ, Bullmore ET, Everitt BJ (2012). Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating. Neuropsycho-pharmacology 37: 2643-2652.
26. Gosnell BA, Levine AS (2009). Reward systems and food intake: role of opioids. Int J Obes 33: S54-S58.
27. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH (2009). The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9: 88.
28. Haghighi A, Melka MG, Bernard M, Abrahamowicz M, Leonard GT, Richer L et al (2013). Opioid receptor mu 1 gene, fat intake and obesity in adolescence. Mol Psychiatry 19: 63-68.
29. Hayward MD, Schaich-Borg A, Pintar JE, Low MJ (2006). Differential involvement of endogenous opioids in sucrose consumption and food reinforcement. Pharmacol Biochem Behav 85: 601-611.
30. Higgs S, Cooper SJ (1998). Evidence for early opioid modulation of licking responses to sucrose and intralipid: a microstructural analysis in the rat. Psychopharmacology 139: 342-355.
31. Jiang ZG, North RA (1992). Pre-and postsynaptic inhibition by opioids in rat striatum. J Neurosci 12: 356-361.
32. Kelley AE, Baldo BA, Pratt WE, Will MJ (2005). Corticostriatal-hypothalamic circuitry and food motivation: Integration of energy, action and reward. Physiol Behav 86: 773-795.
33. König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ et al (1996). Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383: 535-538.
34. Laurent V, Bertran-Gonzalez J, Chieng BC, Balleine BW (2014). δ-opioid and dopaminergic processes in accumbens shell modulate the cholinergic control of predictive learning and choice. J Neurosci 34: 1358-1369.
35. Laurent V, Leung B, Maidment N, Balleine BW (2012). mu-and delta-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice. J Neurosci 32: 1875-1883.
36. Le Merrer J, Becker JAJ, Befort K, Kieffer BL (2009). Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
37. Levine AS, Atkinson RL (1987). Opioids in the regulation of food intake and energy expenditure. Fed Proc 46: 159-162.
38. Levine AS, Weldon DT, Grace M, Cleary JP, Billington CJ (1995). Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. Am J Physiol 268: R248-R252.
39. Liao RM, Ko MC (1995). Chronic effect of haloperidol and SCH23390 on operant and licking behaviors in the rat. Chin J Physiol 38: 65-73.
40. Mahler SV, Berridge KC (2009). Which cue to "want?" Central amygdala opioid activation enhances and focuses incentive salience on a prepotent reward cue. J Neurosci 29: 6500-6513.
41. Mena JD, Sadeghian K, Baldo BA (2011). Induction of hyperphagia and carbohydrate intake by mu-opioid receptor stimulation in circumscribed regions of frontal cortex. J Neurosci 31: 3249-3260.
42. Millington GWM (2007). The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr Metab 4: 18.
43. Mitchell JE, Morley JE, Levine AS, Hatsukami D, Gannon M, Pfohl D (1987). High-dose naltrexone therapy and dietary counseling for obesity. Biol Psychiatry 22: 35-42.
44. Murphy NP (2015). Dynamic measurement of extracellular opioid activity: status quo, challenges, and significance in rewarded behaviors. ACS Chem Neurosci 6: 94-107.
45. Nogueiras R, Romero-Pico A, Vazquez MJ, Novelle MG, Lopez M, Dieguez C (2012). The opioid system and food intake: homeo-static and hedonic mechanisms. Obes Facts 5: 196-207.
46. Ostlund SB, Kosheleff A, Maidment NT, Murphy NP (2013). Decreased consumption of sweet fluids in mu opioid receptor knockout mice: a microstructural analysis of licking behavior. Psychopharmacology 229: 105-113.
47. Pecina S, Smith KS (2010). Hedonic and motivational roles of opioids in food reward:implications for overeating disorders. Pharmacol Biochem Behav 97: 34-46.
48. Reid LD (1985). Endogenous opioid peptides and regulation of drinking and feeding. Am J Clin Nutr 42: 1099-1132.
49. Rubinstein M, Mogil JS, Japón M, Chan EC, Allen RG, Low MJ (1996). Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc Natl Acad Sci USA 93: 3995-4000.
50. Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT et al (2011). Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity 19: 1109-1117.
51. Schneider LH, Davis JD, Watson CA, Smith GP (1990). Similar effect of raclopride and reduced sucrose concentration on the microstructure of sucrose sham feeding. Eur J Pharmacol 186: 61-70.
52. Shaw WN, Mitch CH, Leander JD, Mendelsohn IG, Zimmerman DM (1991). The effect of the opioid antagonist LY255582 on body weight of the obese Zucker rat. Int J Obes 15: 387-395.
53. Smith GP (2004). Accumbens dopamine mediates the rewarding effect of orosensory stimulation by sucrose. Appetite 43: 11-13.
54. Statnick MA, Tinsley FC, Eastwood BJ, Suter TM, Mitch CH, Heiman ML (2003). Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization. Am J Physiol Regul Integr Comp Physiol 284: R1399-R1408.
55. Tabarin A, Chaves YD, Carmona MDC, Catargi B, Zorrila EP, Roberts AJ et al (2005a). Resistance to diet-induced obesity in μ-opioid receptor-deficient mice. Diabetes 54: 3510-3516.
56. Tabarin A, Diz-Chaves Y, Carmona Mdel C, Catargi B, Zorrilla EP, Roberts AJ et al (2005b). Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a "thrifty gene". Diabetes 54: 3510-3516.
57. Wassum KM, Cely IC, Balleine BW, Maidment NT (2011). Micro-opioid receptor activation in the basolateral amygdala mediates the learning of increases but notdecreases in the incentive value of a food reward. J Neurosci 31: 1591-1599.
58. Wheeler E, Huang N, Bochukova EG, Keogh JM, Lindsay S, Garg S et al (2013). Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nat Genet 45: 513-517.
59. Wright FL, Rodgers RJ (2013). Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash. Psychophar-macology 228: 291-307.
60. Yeomans MR, Blundell JE, Leshem M (2004). Palatability: response to nutritional need orneed-free stimulation of appetite? Br J Nutr 92(Suppl 1): S3-14.
61. Yeomans MR, Gray RW (2002). Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 26: 713-728.
62. Zhang M, Gosnell BA, Kelley AE (1998). Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther 285: 908-914.
63. Ziauddeen H, Chamberlain SR, Nathan PJ, Koch A, Maltby K, Bush M et al (2012). Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol Psychiatry 18: 1287-1293.
64. Zuberi AR, Townsend L, Patterson L, Zheng H, Berthoud HR (2008). Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in μ-opioid receptor-deficient mice. Eur J Pharmacol 585: 14-23.